These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 9706119)

  • 1. Prevention of type 1 diabetes.
    Rabinovitch A; Skyler JS
    Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to islet autoantigens in type 1 diabetes.
    Bach JF; Chatenoud L
    Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
    Rabinovitch A; Suarez-Pinzon WL
    Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits.
    Suarez-Pinzon WL; Rabinovitch A
    Int J Exp Diabetes Res; 2001; 2(1):3-17. PubMed ID: 12369724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
    Kallan AA; de Vries RR; Roep BO
    APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.
    Garza KM; McKall-Faienza KJ; Otheki T; Zakarian A; Odermatt B; Ohashi PS
    Eur J Immunol; 2002 Mar; 32(3):885-94. PubMed ID: 11870633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
    Wang B; Tisch R
    Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
    Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
    J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of autoimmune diabetes mellitus.
    Rossini AA; Mordes JP; Greiner DL
    Curr Opin Immunol; 1989-1990 Apr; 2(4):598-603. PubMed ID: 2700903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
    Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
    Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses to autoantigens in IDDM. The search for the Holy Grail.
    Roep BO
    Diabetes; 1996 Sep; 45(9):1147-56. PubMed ID: 8772714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeting of islet autoantigens.
    Stadinski B; Kappler J; Eisenbarth GS
    Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.